Solitary giant neurofibroma of the neck subjected to photodynamic therapy: case study.

Head and Neck Optical Diagnostics Society Pub Date : 2012-01-01 Epub Date: 2012-06-06 DOI:10.1186/1758-3284-4-30
Zaid Hamdoon, Waseem Jerjes, Raed Al-Delayme, Colin Hopper
{"title":"Solitary giant neurofibroma of the neck subjected to photodynamic therapy: case study.","authors":"Zaid Hamdoon,&nbsp;Waseem Jerjes,&nbsp;Raed Al-Delayme,&nbsp;Colin Hopper","doi":"10.1186/1758-3284-4-30","DOIUrl":null,"url":null,"abstract":"<p><p>Photodynamic therapy (PDT) - the fourth modality - has been successfully used in the management of early and advanced pathologies of the head and neck. We studied the effect of this modality on a giant solitary neurofibroma of the neck. A 70-year-old Caucasian female presented with left neck pain and disfigurement associated with slight shortness of breath and dysphagia. Examination revealed a large mass in the neck with no neurovascular compromise. Magnetic resonance imaging (MRI) reported a heterogeneously enhancing mass extending from the left angle of the mandible to the base of the neck. A core biopsy was performed and histopathological examination revealed a disorganised array of peripheral nerve fascicles. The patient elected to receive photodynamic therapy as the primary intervention. The multi-disciplinary meeting approved the treatment plan. The photosensitizing agent was mTHPC (0.15 mg/kg), which was systemically administered 96-hours prior to ultrasound (US)-guided light delivery to the mass, which was undertaken under general anaesthesia. Recovery was uneventful. Post-PDT follow-up showed that the patient's pain, dysphagia and shortness of breath issues had improved. The disfigurement of the neck caused by the mass was no longer a problem. Three months post-PDT, MRI revealed a significant reduction in the neurofibroma size. PDT was proven as a successful primary intervention for this pathology. However, higher evidence-based studies are required before this therapy can be proposed as a replacement to any of the other conventional therapies.</p>","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1758-3284-4-30","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Head and Neck Optical Diagnostics Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1758-3284-4-30","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/6/6 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 17

Abstract

Photodynamic therapy (PDT) - the fourth modality - has been successfully used in the management of early and advanced pathologies of the head and neck. We studied the effect of this modality on a giant solitary neurofibroma of the neck. A 70-year-old Caucasian female presented with left neck pain and disfigurement associated with slight shortness of breath and dysphagia. Examination revealed a large mass in the neck with no neurovascular compromise. Magnetic resonance imaging (MRI) reported a heterogeneously enhancing mass extending from the left angle of the mandible to the base of the neck. A core biopsy was performed and histopathological examination revealed a disorganised array of peripheral nerve fascicles. The patient elected to receive photodynamic therapy as the primary intervention. The multi-disciplinary meeting approved the treatment plan. The photosensitizing agent was mTHPC (0.15 mg/kg), which was systemically administered 96-hours prior to ultrasound (US)-guided light delivery to the mass, which was undertaken under general anaesthesia. Recovery was uneventful. Post-PDT follow-up showed that the patient's pain, dysphagia and shortness of breath issues had improved. The disfigurement of the neck caused by the mass was no longer a problem. Three months post-PDT, MRI revealed a significant reduction in the neurofibroma size. PDT was proven as a successful primary intervention for this pathology. However, higher evidence-based studies are required before this therapy can be proposed as a replacement to any of the other conventional therapies.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
单发巨大的颈部神经纤维瘤接受光动力治疗:个案研究。
光动力疗法(PDT) -第四种模式-已成功地用于头颈部早期和晚期病理的管理。我们研究了这种方式对颈部巨大孤立神经纤维瘤的影响。一位70岁的白人女性表现为左颈部疼痛和毁容,伴有轻微呼吸短促和吞咽困难。检查发现颈部有一个大肿块,未见神经血管受损。磁共振成像(MRI)报告了一个非均匀增强的肿块,从下颌骨的左角延伸到颈部的底部。进行了核心活检,组织病理学检查显示周围神经束排列紊乱。患者选择接受光动力治疗作为主要干预。多学科会议批准了治疗方案。光敏剂为mTHPC (0.15 mg/kg),在全身麻醉下,于超声(US)引导光照射肿块前96小时全身给药。恢复过程平淡无奇。pdt后随访显示,患者的疼痛、吞咽困难和呼吸短促问题有所改善。由肿块引起的颈部畸形不再是一个问题。pdt后3个月,MRI显示神经纤维瘤大小明显减小。PDT被证明是一种成功的初级干预这种病理。然而,在提出这种疗法替代任何其他传统疗法之前,需要更高的循证研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Prevalence and Pattern of Cervical Nodal Metastasis of Upper Aerodigestive Tract Squamous at the Time of Diagnosis in Patients Attending Tikur Anbessa Hospital from September 2015 to September 2020 An Inclusion Epidermoid Cyst, a Rare Complication of Versatile Naso-Labial Flap Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma. Intercondylar distance before and after mandible resection Effect of human beta-defensin-3 on head and neck cancer cell migration using micro-fabricated cell islands.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1